Real-world experience of carfilzomib-associated cardiovascular adverse events: SEER-Medicare data set analysis.

As previously reported in the literature, we also identified highly significant HR for heart failure, ischemic heart disease, and hypertension while there was no association with conduction disorders (arrhythmia and blocks).

also in 132,142 other papers